Literature DB >> 6498676

Hereditary central diabetes insipidus: plasma levels of antidiuretic hormone in a family with a possible osmoreceptor defect.

E L Toth, P A Bowen, P M Crockford.   

Abstract

A large Canadian kindred of Irish extraction extending from Quebec to British Columbia with autosomal dominant diabetes insipidus responsive to exogenous antidiuretic hormone (ADH) is described. Out of 121 individuals 34 have been identified as affected in seven generations. The disorder is characterized by variability in age at onset and in severity, and by apparently spontaneous abatement in old age. The affected subjects do not appear to manifest hypertension or its sequelae. In three individuals tested the plasma ADH level was very low in spite of adequate osmotic stimulation. However, the level rose in two of them when they were given furosemide, which suggests an osmoreceptor defect and a normal ADH response to volume change.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498676      PMCID: PMC1483705     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  28 in total

1.  ASYMPTOMATIC HYPERNATREMIA: PHYSIOLOGICAL AND CLINICAL STUDY.

Authors:  A J KASTIN; M B LIPSETT; A K OMMAYA; J M MOSER
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

2.  HEREDITARY IDIOPATHIC DIABETES INSIPIDUS. A CASE REPORT WITH AUTOPSY FINDINGS.

Authors:  L E BRAVERMAN; J P MANCINI; D M MCGOLDRICK
Journal:  Ann Intern Med       Date:  1965-09       Impact factor: 25.391

3.  Familial diabetes insipidus.

Authors:  F I MARTIN
Journal:  Q J Med       Date:  1959-10

4.  Primary or idiopathic diabetes insipidus: a system disease.

Authors:  H BLOTNER
Journal:  Metabolism       Date:  1958-05       Impact factor: 8.694

5.  Dominant inheritance of diabetes insipidus; a family study.

Authors:  C B PENDER; F C FRASER
Journal:  Pediatrics       Date:  1953-03       Impact factor: 7.124

6.  "Essential" hypernatremia due to ineffective osmotic and intact volume regulation of vasopressin secretion.

Authors:  F R DeRubertis; M F Michelis; N Beck; J B Field; B B Davis
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

7.  Pathophysiologic and pharmacologic alterations in the release and action of ADH.

Authors:  A M Moses; M Miller; D H Streeten
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

8.  Radioimmunoassay of 8-arginine-vasopressin (antidiuretic hormone) in human plasma.

Authors:  M Hammer
Journal:  Scand J Clin Lab Invest       Date:  1978-12       Impact factor: 1.713

9.  Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.

Authors:  G L Robertson; E A Mahr; S Athar; T Sinha
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  Radioimmunoassay of vasopressin in familial cental diabetes insipidus.

Authors:  P B Kaplowitz; A J D'Ercole; G L Robertson
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

View more
  1 in total

1.  Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.

Authors:  S Rittig; G L Robertson; C Siggaard; L Kovács; N Gregersen; J Nyborg; E B Pedersen
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.